Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial

OBJECTIVE: To determine the effect of erenumab, a human anti-calcitonin gene-related peptide receptor monoclonal antibody, in patients with chronic migraine and medication overuse. METHODS: In this double-blind, placebo-controlled study, 667 adults with chronic migraine were randomized (3:2:2) to pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Stewart J., Diener, Hans-Christoph, Ashina, Messoud, Brandes, Jan Lewis, Friedman, Deborah I., Reuter, Uwe, Cheng, Sunfa, Nilsen, Jon, Leonardi, Dean K., Lenz, Robert A., Mikol, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598821/
https://www.ncbi.nlm.nih.gov/pubmed/30996056
http://dx.doi.org/10.1212/WNL.0000000000007497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598821/
https://www.ncbi.nlm.nih.gov/pubmed/30996056
http://dx.doi.org/10.1212/WNL.0000000000007497

Ejemplares similares